“Revolutionizing drug discovery in lung cancer: An artificial intelligence (AI)-assisted framework for identifying target antigens for antibody-drug conjugates”, IJBB, vol. 63, no. 2, pp. 137–144, Jan. 2026, doi: 10.56042/ijbb.v63i2.22387.